15-59137741-G-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_004998.4(MYO1E):​c.3251-285C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.3 in 152,106 control chromosomes in the GnomAD database, including 7,005 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.30 ( 7005 hom., cov: 32)

Consequence

MYO1E
NM_004998.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 0.393

Publications

2 publications found
Variant links:
Genes affected
MYO1E (HGNC:7599): (myosin IE) This gene encodes a member of the nonmuscle class I myosins which are a subgroup of the unconventional myosin protein family. The unconventional myosin proteins function as actin-based molecular motors. Class I myosins are characterized by a head (motor) domain, a regulatory domain and a either a short or long tail domain. Among the class I myosins, this protein is distinguished by a long tail domain that is involved in crosslinking actin filaments. This protein localizes to the cytoplasm and may be involved in intracellular movement and membrane trafficking. Mutations in this gene are the cause of focal segmental glomerulosclerosis-6. This gene has been referred to as myosin IC in the literature but is distinct from the myosin IC gene located on chromosome 17. [provided by RefSeq, Jan 2012]
MYO1E Gene-Disease associations (from GenCC):
  • focal segmental glomerulosclerosis 6
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • familial idiopathic steroid-resistant nephrotic syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 15-59137741-G-C is Benign according to our data. Variant chr15-59137741-G-C is described in ClinVar as Benign. ClinVar VariationId is 1180130.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.399 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_004998.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MYO1E
NM_004998.4
MANE Select
c.3251-285C>G
intron
N/ANP_004989.2Q4KMR3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MYO1E
ENST00000288235.9
TSL:1 MANE Select
c.3251-285C>G
intron
N/AENSP00000288235.4Q12965
MYO1E
ENST00000884343.1
c.3284-285C>G
intron
N/AENSP00000554402.1
MYO1E
ENST00000884345.1
c.3224-285C>G
intron
N/AENSP00000554404.1

Frequencies

GnomAD3 genomes
AF:
0.300
AC:
45537
AN:
151988
Hom.:
6998
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.242
Gnomad AMI
AF:
0.349
Gnomad AMR
AF:
0.392
Gnomad ASJ
AF:
0.323
Gnomad EAS
AF:
0.414
Gnomad SAS
AF:
0.240
Gnomad FIN
AF:
0.299
Gnomad MID
AF:
0.392
Gnomad NFE
AF:
0.307
Gnomad OTH
AF:
0.316
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.300
AC:
45564
AN:
152106
Hom.:
7005
Cov.:
32
AF XY:
0.300
AC XY:
22328
AN XY:
74366
show subpopulations
African (AFR)
AF:
0.242
AC:
10043
AN:
41484
American (AMR)
AF:
0.392
AC:
5993
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.323
AC:
1122
AN:
3470
East Asian (EAS)
AF:
0.414
AC:
2140
AN:
5168
South Asian (SAS)
AF:
0.240
AC:
1160
AN:
4830
European-Finnish (FIN)
AF:
0.299
AC:
3163
AN:
10582
Middle Eastern (MID)
AF:
0.381
AC:
112
AN:
294
European-Non Finnish (NFE)
AF:
0.307
AC:
20845
AN:
67970
Other (OTH)
AF:
0.317
AC:
668
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1623
3246
4870
6493
8116
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
460
920
1380
1840
2300
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.173
Hom.:
351
Bravo
AF:
0.308
Asia WGS
AF:
0.334
AC:
1160
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not provided (2)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
0.21
DANN
Benign
0.29
PhyloP100
0.39
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs56375269; hg19: chr15-59429940; COSMIC: COSV107299537; COSMIC: COSV107299537; API